Testing effectiveness (Phase 2)Study completedNCT05254899
What this trial is testing
Tislelizumab, Chemotherapy, and Radiation Therapy for Early-Stage High-Risk ENKTCL (CLCG-2102)
Who this might be right for
Extranodal NK-T-Cell LymphomaEarly-stageHigh-Risk Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 54